Participants
| Role | Name | HCID | Charge |
|---|
| Reactant | Methane | HCID 297 | — |
| Reactant | 1-Amino-4-methylpiperazine | HCID 81349 | — |
| Reactant | 11-chlorocarbonyl-5,11-dihydro-6H-pyrido[2,3-b][1,4]benzodiazepin-6-one | HCID 11043962 | — |
| Solvent | 1,4-Dioxane | HCID 31275 | — |
| Product | HCID 20475065 | HCID 20475065 | — |
Reaction Steps
A mixture of 5.5 g (0.0201 mol) of 11-chlorocarbonyl-5,11-dihydro-6H-pyrido[2,3-b][1,4]benzodiazepin-6-one, 6.9 g (0.06 mol) of 1-amino-4-methylpiperazine and 150 ml of anhydrous dioxane was heated for 30 minutes over a steam bath and the cloudy reaction mixture obtained was then mixed while still hot with 2 g of active charcoal, then filtered and the filtrate obtained was concentrated by evaporation in vacuo. The residue was purified by column chromatography on 300 g of silica gel, using a mixture of dichloromethane, methanol and conc. aqueous ammonia (ratio by volume 800:200:5). The residue remaining after the eluates of interest had been evaporated was recrystallized from ethanol. 1.5 g (19% of theory) of colorless crystals of 5,11-dihydro-11-[[(4-methyl-1-piperazinyl)amino]-carbonyl]-6H-pyrido[2,3-b]-[1,4]benzodiazepin-6-one hydrochloride hydrate was obtained,
Provenance & Evidence
| DOI | 10.6084/m9.figshare.5104873.v1 |
|---|
| Patent number | US04424222 |
|---|
| Source dataset | uspto-grants-1984_01 |
|---|
| ORD ID | ord-ca8e9eb52080477380a092a0d672e351 |
|---|
| Source note | uspto-grants-1984_01 |
|---|